Immune response to the third COVID-19 vaccine dose is related to lymphocyte count in multiple sclerosis patients treated with fingolimod Article Swipe
Anat Achiron
,
Mathilda Mandel
,
Michael Gurevich
,
Sapir Dreyer-Alster
,
David Magalashvili
,
Polina Sonis
,
Mark Dolev
,
Shay Menascu
,
Gil Harari
,
Shlomo Flechter
,
Rina Falb
·
YOU?
·
· 2022
· Open Access
·
· DOI: https://doi.org/10.1007/s00415-022-11030-0
YOU?
·
· 2022
· Open Access
·
· DOI: https://doi.org/10.1007/s00415-022-11030-0
Related Topics
Concepts
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1007/s00415-022-11030-0
- https://link.springer.com/content/pdf/10.1007/s00415-022-11030-0.pdf
- OA Status
- bronze
- Cited By
- 44
- References
- 22
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4214879309
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4214879309Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1007/s00415-022-11030-0Digital Object Identifier
- Title
-
Immune response to the third COVID-19 vaccine dose is related to lymphocyte count in multiple sclerosis patients treated with fingolimodWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2022Year of publication
- Publication date
-
2022-03-02Full publication date if available
- Authors
-
Anat Achiron, Mathilda Mandel, Michael Gurevich, Sapir Dreyer-Alster, David Magalashvili, Polina Sonis, Mark Dolev, Shay Menascu, Gil Harari, Shlomo Flechter, Rina FalbList of authors in order
- Landing page
-
https://doi.org/10.1007/s00415-022-11030-0Publisher landing page
- PDF URL
-
https://link.springer.com/content/pdf/10.1007/s00415-022-11030-0.pdfDirect link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
bronzeOpen access status per OpenAlex
- OA URL
-
https://link.springer.com/content/pdf/10.1007/s00415-022-11030-0.pdfDirect OA link when available
- Concepts
-
Fingolimod, Medicine, Discontinuation, Immunology, Immune system, Natalizumab, Multiple sclerosis, Vaccination, Cellular immunity, Internal medicineTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
44Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 5, 2024: 5, 2023: 17, 2022: 17Per-year citation counts (last 5 years)
- References (count)
-
22Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4214879309 |
|---|---|
| doi | https://doi.org/10.1007/s00415-022-11030-0 |
| ids.doi | https://doi.org/10.1007/s00415-022-11030-0 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/35235002 |
| ids.openalex | https://openalex.org/W4214879309 |
| fwci | 9.12005494 |
| mesh[0].qualifier_ui | |
| mesh[0].descriptor_ui | D000914 |
| mesh[0].is_major_topic | False |
| mesh[0].qualifier_name | |
| mesh[0].descriptor_name | Antibodies, Viral |
| mesh[1].qualifier_ui | |
| mesh[1].descriptor_ui | D000090982 |
| mesh[1].is_major_topic | False |
| mesh[1].qualifier_name | |
| mesh[1].descriptor_name | BNT162 Vaccine |
| mesh[2].qualifier_ui | Q000517 |
| mesh[2].descriptor_ui | D000086382 |
| mesh[2].is_major_topic | True |
| mesh[2].qualifier_name | prevention & control |
| mesh[2].descriptor_name | COVID-19 |
| mesh[3].qualifier_ui | |
| mesh[3].descriptor_ui | D000086663 |
| mesh[3].is_major_topic | False |
| mesh[3].qualifier_name | |
| mesh[3].descriptor_name | COVID-19 Vaccines |
| mesh[4].qualifier_ui | Q000627 |
| mesh[4].descriptor_ui | D000068876 |
| mesh[4].is_major_topic | False |
| mesh[4].qualifier_name | therapeutic use |
| mesh[4].descriptor_name | Fingolimod Hydrochloride |
| mesh[5].qualifier_ui | |
| mesh[5].descriptor_ui | D006801 |
| mesh[5].is_major_topic | False |
| mesh[5].qualifier_name | |
| mesh[5].descriptor_name | Humans |
| mesh[6].qualifier_ui | |
| mesh[6].descriptor_ui | D007109 |
| mesh[6].is_major_topic | False |
| mesh[6].qualifier_name | |
| mesh[6].descriptor_name | Immunity |
| mesh[7].qualifier_ui | |
| mesh[7].descriptor_ui | D007074 |
| mesh[7].is_major_topic | False |
| mesh[7].qualifier_name | |
| mesh[7].descriptor_name | Immunoglobulin G |
| mesh[8].qualifier_ui | |
| mesh[8].descriptor_ui | D018655 |
| mesh[8].is_major_topic | False |
| mesh[8].qualifier_name | |
| mesh[8].descriptor_name | Lymphocyte Count |
| mesh[9].qualifier_ui | Q000188 |
| mesh[9].descriptor_ui | D009103 |
| mesh[9].is_major_topic | True |
| mesh[9].qualifier_name | drug therapy |
| mesh[9].descriptor_name | Multiple Sclerosis |
| mesh[10].qualifier_ui | |
| mesh[10].descriptor_ui | D011446 |
| mesh[10].is_major_topic | False |
| mesh[10].qualifier_name | |
| mesh[10].descriptor_name | Prospective Studies |
| mesh[11].qualifier_ui | |
| mesh[11].descriptor_ui | D000086402 |
| mesh[11].is_major_topic | False |
| mesh[11].qualifier_name | |
| mesh[11].descriptor_name | SARS-CoV-2 |
| mesh[12].qualifier_ui | |
| mesh[12].descriptor_ui | D000914 |
| mesh[12].is_major_topic | False |
| mesh[12].qualifier_name | |
| mesh[12].descriptor_name | Antibodies, Viral |
| mesh[13].qualifier_ui | |
| mesh[13].descriptor_ui | D000090982 |
| mesh[13].is_major_topic | False |
| mesh[13].qualifier_name | |
| mesh[13].descriptor_name | BNT162 Vaccine |
| mesh[14].qualifier_ui | Q000517 |
| mesh[14].descriptor_ui | D000086382 |
| mesh[14].is_major_topic | True |
| mesh[14].qualifier_name | prevention & control |
| mesh[14].descriptor_name | COVID-19 |
| mesh[15].qualifier_ui | |
| mesh[15].descriptor_ui | D000086663 |
| mesh[15].is_major_topic | False |
| mesh[15].qualifier_name | |
| mesh[15].descriptor_name | COVID-19 Vaccines |
| mesh[16].qualifier_ui | Q000627 |
| mesh[16].descriptor_ui | D000068876 |
| mesh[16].is_major_topic | False |
| mesh[16].qualifier_name | therapeutic use |
| mesh[16].descriptor_name | Fingolimod Hydrochloride |
| mesh[17].qualifier_ui | |
| mesh[17].descriptor_ui | D006801 |
| mesh[17].is_major_topic | False |
| mesh[17].qualifier_name | |
| mesh[17].descriptor_name | Humans |
| mesh[18].qualifier_ui | |
| mesh[18].descriptor_ui | D007109 |
| mesh[18].is_major_topic | False |
| mesh[18].qualifier_name | |
| mesh[18].descriptor_name | Immunity |
| mesh[19].qualifier_ui | |
| mesh[19].descriptor_ui | D007074 |
| mesh[19].is_major_topic | False |
| mesh[19].qualifier_name | |
| mesh[19].descriptor_name | Immunoglobulin G |
| mesh[20].qualifier_ui | |
| mesh[20].descriptor_ui | D018655 |
| mesh[20].is_major_topic | False |
| mesh[20].qualifier_name | |
| mesh[20].descriptor_name | Lymphocyte Count |
| mesh[21].qualifier_ui | Q000188 |
| mesh[21].descriptor_ui | D009103 |
| mesh[21].is_major_topic | True |
| mesh[21].qualifier_name | drug therapy |
| mesh[21].descriptor_name | Multiple Sclerosis |
| mesh[22].qualifier_ui | |
| mesh[22].descriptor_ui | D011446 |
| mesh[22].is_major_topic | False |
| mesh[22].qualifier_name | |
| mesh[22].descriptor_name | Prospective Studies |
| mesh[23].qualifier_ui | |
| mesh[23].descriptor_ui | D000086402 |
| mesh[23].is_major_topic | False |
| mesh[23].qualifier_name | |
| mesh[23].descriptor_name | SARS-CoV-2 |
| type | article |
| title | Immune response to the third COVID-19 vaccine dose is related to lymphocyte count in multiple sclerosis patients treated with fingolimod |
| biblio.issue | 5 |
| biblio.volume | 269 |
| biblio.last_page | 2292 |
| biblio.first_page | 2286 |
| topics[0].id | https://openalex.org/T10137 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9998999834060669 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2734 |
| topics[0].subfield.display_name | Pathology and Forensic Medicine |
| topics[0].display_name | Multiple Sclerosis Research Studies |
| topics[1].id | https://openalex.org/T10118 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9983999729156494 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2725 |
| topics[1].subfield.display_name | Infectious Diseases |
| topics[1].display_name | SARS-CoV-2 and COVID-19 Research |
| topics[2].id | https://openalex.org/T11735 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9950000047683716 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2728 |
| topics[2].subfield.display_name | Neurology |
| topics[2].display_name | Peripheral Neuropathies and Disorders |
| is_xpac | False |
| apc_list.value | 3290 |
| apc_list.currency | EUR |
| apc_list.value_usd | 4190 |
| apc_paid | |
| concepts[0].id | https://openalex.org/C2776036978 |
| concepts[0].level | 3 |
| concepts[0].score | 0.9812678098678589 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q425137 |
| concepts[0].display_name | Fingolimod |
| concepts[1].id | https://openalex.org/C71924100 |
| concepts[1].level | 0 |
| concepts[1].score | 0.8430513739585876 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[1].display_name | Medicine |
| concepts[2].id | https://openalex.org/C2778715236 |
| concepts[2].level | 2 |
| concepts[2].score | 0.6392881870269775 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q55622662 |
| concepts[2].display_name | Discontinuation |
| concepts[3].id | https://openalex.org/C203014093 |
| concepts[3].level | 1 |
| concepts[3].score | 0.6083316206932068 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q101929 |
| concepts[3].display_name | Immunology |
| concepts[4].id | https://openalex.org/C8891405 |
| concepts[4].level | 2 |
| concepts[4].score | 0.5985241532325745 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q1059 |
| concepts[4].display_name | Immune system |
| concepts[5].id | https://openalex.org/C2781004633 |
| concepts[5].level | 3 |
| concepts[5].score | 0.5427963137626648 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q386119 |
| concepts[5].display_name | Natalizumab |
| concepts[6].id | https://openalex.org/C2780640218 |
| concepts[6].level | 2 |
| concepts[6].score | 0.5142428278923035 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q8277 |
| concepts[6].display_name | Multiple sclerosis |
| concepts[7].id | https://openalex.org/C22070199 |
| concepts[7].level | 2 |
| concepts[7].score | 0.49066007137298584 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q192995 |
| concepts[7].display_name | Vaccination |
| concepts[8].id | https://openalex.org/C3017875465 |
| concepts[8].level | 3 |
| concepts[8].score | 0.48532551527023315 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q189146 |
| concepts[8].display_name | Cellular immunity |
| concepts[9].id | https://openalex.org/C126322002 |
| concepts[9].level | 1 |
| concepts[9].score | 0.32860058546066284 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[9].display_name | Internal medicine |
| keywords[0].id | https://openalex.org/keywords/fingolimod |
| keywords[0].score | 0.9812678098678589 |
| keywords[0].display_name | Fingolimod |
| keywords[1].id | https://openalex.org/keywords/medicine |
| keywords[1].score | 0.8430513739585876 |
| keywords[1].display_name | Medicine |
| keywords[2].id | https://openalex.org/keywords/discontinuation |
| keywords[2].score | 0.6392881870269775 |
| keywords[2].display_name | Discontinuation |
| keywords[3].id | https://openalex.org/keywords/immunology |
| keywords[3].score | 0.6083316206932068 |
| keywords[3].display_name | Immunology |
| keywords[4].id | https://openalex.org/keywords/immune-system |
| keywords[4].score | 0.5985241532325745 |
| keywords[4].display_name | Immune system |
| keywords[5].id | https://openalex.org/keywords/natalizumab |
| keywords[5].score | 0.5427963137626648 |
| keywords[5].display_name | Natalizumab |
| keywords[6].id | https://openalex.org/keywords/multiple-sclerosis |
| keywords[6].score | 0.5142428278923035 |
| keywords[6].display_name | Multiple sclerosis |
| keywords[7].id | https://openalex.org/keywords/vaccination |
| keywords[7].score | 0.49066007137298584 |
| keywords[7].display_name | Vaccination |
| keywords[8].id | https://openalex.org/keywords/cellular-immunity |
| keywords[8].score | 0.48532551527023315 |
| keywords[8].display_name | Cellular immunity |
| keywords[9].id | https://openalex.org/keywords/internal-medicine |
| keywords[9].score | 0.32860058546066284 |
| keywords[9].display_name | Internal medicine |
| language | en |
| locations[0].id | doi:10.1007/s00415-022-11030-0 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S175814247 |
| locations[0].source.issn | 0340-5354, 1432-1459 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | False |
| locations[0].source.issn_l | 0340-5354 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | Journal of Neurology |
| locations[0].source.host_organization | https://openalex.org/P4310319900 |
| locations[0].source.host_organization_name | Springer Science+Business Media |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310319900, https://openalex.org/P4310319965 |
| locations[0].source.host_organization_lineage_names | Springer Science+Business Media, Springer Nature |
| locations[0].license | |
| locations[0].pdf_url | https://link.springer.com/content/pdf/10.1007/s00415-022-11030-0.pdf |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Journal of Neurology |
| locations[0].landing_page_url | https://doi.org/10.1007/s00415-022-11030-0 |
| locations[1].id | pmid:35235002 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | Journal of neurology |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/35235002 |
| locations[2].id | pmh:oai:pubmedcentral.nih.gov:8889521 |
| locations[2].is_oa | True |
| locations[2].source.id | https://openalex.org/S2764455111 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | PubMed Central |
| locations[2].source.host_organization | https://openalex.org/I1299303238 |
| locations[2].source.host_organization_name | National Institutes of Health |
| locations[2].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[2].license | |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | Text |
| locations[2].license_id | |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | J Neurol |
| locations[2].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/8889521 |
| indexed_in | crossref, pubmed |
| authorships[0].author.id | https://openalex.org/A5075594305 |
| authorships[0].author.orcid | https://orcid.org/0000-0002-2020-3126 |
| authorships[0].author.display_name | Anat Achiron |
| authorships[0].countries | IL |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I16391192, https://openalex.org/I2799810450 |
| authorships[0].affiliations[0].raw_affiliation_string | Neuroimmunology Laboratory at the Multiple Sclerosis Center, Sheba Medical Center, Laura Schwarz-Kipp Research of Autoimmune Diseases, Sackler School of Medicine Tel-Aviv University, Ramat-Gann, Israel |
| authorships[0].institutions[0].id | https://openalex.org/I2799810450 |
| authorships[0].institutions[0].ror | https://ror.org/020rzx487 |
| authorships[0].institutions[0].type | healthcare |
| authorships[0].institutions[0].lineage | https://openalex.org/I2799810450 |
| authorships[0].institutions[0].country_code | IL |
| authorships[0].institutions[0].display_name | Sheba Medical Center |
| authorships[0].institutions[1].id | https://openalex.org/I16391192 |
| authorships[0].institutions[1].ror | https://ror.org/04mhzgx49 |
| authorships[0].institutions[1].type | education |
| authorships[0].institutions[1].lineage | https://openalex.org/I16391192 |
| authorships[0].institutions[1].country_code | IL |
| authorships[0].institutions[1].display_name | Tel Aviv University |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Anat Achiron |
| authorships[0].is_corresponding | True |
| authorships[0].raw_affiliation_strings | Neuroimmunology Laboratory at the Multiple Sclerosis Center, Sheba Medical Center, Laura Schwarz-Kipp Research of Autoimmune Diseases, Sackler School of Medicine Tel-Aviv University, Ramat-Gann, Israel |
| authorships[1].author.id | https://openalex.org/A5109971084 |
| authorships[1].author.orcid | |
| authorships[1].author.display_name | Mathilda Mandel |
| authorships[1].countries | IL |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I16391192, https://openalex.org/I2799810450 |
| authorships[1].affiliations[0].raw_affiliation_string | Neuroimmunology Laboratory at the Multiple Sclerosis Center, Sheba Medical Center, Laura Schwarz-Kipp Research of Autoimmune Diseases, Sackler School of Medicine Tel-Aviv University, Ramat-Gann, Israel |
| authorships[1].institutions[0].id | https://openalex.org/I2799810450 |
| authorships[1].institutions[0].ror | https://ror.org/020rzx487 |
| authorships[1].institutions[0].type | healthcare |
| authorships[1].institutions[0].lineage | https://openalex.org/I2799810450 |
| authorships[1].institutions[0].country_code | IL |
| authorships[1].institutions[0].display_name | Sheba Medical Center |
| authorships[1].institutions[1].id | https://openalex.org/I16391192 |
| authorships[1].institutions[1].ror | https://ror.org/04mhzgx49 |
| authorships[1].institutions[1].type | education |
| authorships[1].institutions[1].lineage | https://openalex.org/I16391192 |
| authorships[1].institutions[1].country_code | IL |
| authorships[1].institutions[1].display_name | Tel Aviv University |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Mathilda Mandel |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Neuroimmunology Laboratory at the Multiple Sclerosis Center, Sheba Medical Center, Laura Schwarz-Kipp Research of Autoimmune Diseases, Sackler School of Medicine Tel-Aviv University, Ramat-Gann, Israel |
| authorships[2].author.id | https://openalex.org/A5017275193 |
| authorships[2].author.orcid | https://orcid.org/0000-0003-1529-4876 |
| authorships[2].author.display_name | Michael Gurevich |
| authorships[2].countries | IL |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I16391192, https://openalex.org/I2799810450 |
| authorships[2].affiliations[0].raw_affiliation_string | Neuroimmunology Laboratory at the Multiple Sclerosis Center, Sheba Medical Center, Laura Schwarz-Kipp Research of Autoimmune Diseases, Sackler School of Medicine Tel-Aviv University, Ramat-Gann, Israel |
| authorships[2].institutions[0].id | https://openalex.org/I2799810450 |
| authorships[2].institutions[0].ror | https://ror.org/020rzx487 |
| authorships[2].institutions[0].type | healthcare |
| authorships[2].institutions[0].lineage | https://openalex.org/I2799810450 |
| authorships[2].institutions[0].country_code | IL |
| authorships[2].institutions[0].display_name | Sheba Medical Center |
| authorships[2].institutions[1].id | https://openalex.org/I16391192 |
| authorships[2].institutions[1].ror | https://ror.org/04mhzgx49 |
| authorships[2].institutions[1].type | education |
| authorships[2].institutions[1].lineage | https://openalex.org/I16391192 |
| authorships[2].institutions[1].country_code | IL |
| authorships[2].institutions[1].display_name | Tel Aviv University |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Michael Gurevich |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Neuroimmunology Laboratory at the Multiple Sclerosis Center, Sheba Medical Center, Laura Schwarz-Kipp Research of Autoimmune Diseases, Sackler School of Medicine Tel-Aviv University, Ramat-Gann, Israel |
| authorships[3].author.id | https://openalex.org/A5025785826 |
| authorships[3].author.orcid | https://orcid.org/0000-0002-7475-1902 |
| authorships[3].author.display_name | Sapir Dreyer-Alster |
| authorships[3].countries | IL |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I16391192, https://openalex.org/I2799810450 |
| authorships[3].affiliations[0].raw_affiliation_string | Neuroimmunology Laboratory at the Multiple Sclerosis Center, Sheba Medical Center, Laura Schwarz-Kipp Research of Autoimmune Diseases, Sackler School of Medicine Tel-Aviv University, Ramat-Gann, Israel |
| authorships[3].institutions[0].id | https://openalex.org/I2799810450 |
| authorships[3].institutions[0].ror | https://ror.org/020rzx487 |
| authorships[3].institutions[0].type | healthcare |
| authorships[3].institutions[0].lineage | https://openalex.org/I2799810450 |
| authorships[3].institutions[0].country_code | IL |
| authorships[3].institutions[0].display_name | Sheba Medical Center |
| authorships[3].institutions[1].id | https://openalex.org/I16391192 |
| authorships[3].institutions[1].ror | https://ror.org/04mhzgx49 |
| authorships[3].institutions[1].type | education |
| authorships[3].institutions[1].lineage | https://openalex.org/I16391192 |
| authorships[3].institutions[1].country_code | IL |
| authorships[3].institutions[1].display_name | Tel Aviv University |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Sapir Dreyer-Alster |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Neuroimmunology Laboratory at the Multiple Sclerosis Center, Sheba Medical Center, Laura Schwarz-Kipp Research of Autoimmune Diseases, Sackler School of Medicine Tel-Aviv University, Ramat-Gann, Israel |
| authorships[4].author.id | https://openalex.org/A5068320881 |
| authorships[4].author.orcid | https://orcid.org/0000-0003-0133-5040 |
| authorships[4].author.display_name | David Magalashvili |
| authorships[4].countries | IL |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I16391192, https://openalex.org/I2799810450 |
| authorships[4].affiliations[0].raw_affiliation_string | Neuroimmunology Laboratory at the Multiple Sclerosis Center, Sheba Medical Center, Laura Schwarz-Kipp Research of Autoimmune Diseases, Sackler School of Medicine Tel-Aviv University, Ramat-Gann, Israel |
| authorships[4].institutions[0].id | https://openalex.org/I2799810450 |
| authorships[4].institutions[0].ror | https://ror.org/020rzx487 |
| authorships[4].institutions[0].type | healthcare |
| authorships[4].institutions[0].lineage | https://openalex.org/I2799810450 |
| authorships[4].institutions[0].country_code | IL |
| authorships[4].institutions[0].display_name | Sheba Medical Center |
| authorships[4].institutions[1].id | https://openalex.org/I16391192 |
| authorships[4].institutions[1].ror | https://ror.org/04mhzgx49 |
| authorships[4].institutions[1].type | education |
| authorships[4].institutions[1].lineage | https://openalex.org/I16391192 |
| authorships[4].institutions[1].country_code | IL |
| authorships[4].institutions[1].display_name | Tel Aviv University |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | David Magalashvili |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Neuroimmunology Laboratory at the Multiple Sclerosis Center, Sheba Medical Center, Laura Schwarz-Kipp Research of Autoimmune Diseases, Sackler School of Medicine Tel-Aviv University, Ramat-Gann, Israel |
| authorships[5].author.id | https://openalex.org/A5039200406 |
| authorships[5].author.orcid | |
| authorships[5].author.display_name | Polina Sonis |
| authorships[5].countries | IL |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I16391192, https://openalex.org/I2799810450 |
| authorships[5].affiliations[0].raw_affiliation_string | Neuroimmunology Laboratory at the Multiple Sclerosis Center, Sheba Medical Center, Laura Schwarz-Kipp Research of Autoimmune Diseases, Sackler School of Medicine Tel-Aviv University, Ramat-Gann, Israel |
| authorships[5].institutions[0].id | https://openalex.org/I2799810450 |
| authorships[5].institutions[0].ror | https://ror.org/020rzx487 |
| authorships[5].institutions[0].type | healthcare |
| authorships[5].institutions[0].lineage | https://openalex.org/I2799810450 |
| authorships[5].institutions[0].country_code | IL |
| authorships[5].institutions[0].display_name | Sheba Medical Center |
| authorships[5].institutions[1].id | https://openalex.org/I16391192 |
| authorships[5].institutions[1].ror | https://ror.org/04mhzgx49 |
| authorships[5].institutions[1].type | education |
| authorships[5].institutions[1].lineage | https://openalex.org/I16391192 |
| authorships[5].institutions[1].country_code | IL |
| authorships[5].institutions[1].display_name | Tel Aviv University |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Polina Sonis |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Neuroimmunology Laboratory at the Multiple Sclerosis Center, Sheba Medical Center, Laura Schwarz-Kipp Research of Autoimmune Diseases, Sackler School of Medicine Tel-Aviv University, Ramat-Gann, Israel |
| authorships[6].author.id | https://openalex.org/A5043474962 |
| authorships[6].author.orcid | https://orcid.org/0000-0001-8181-9226 |
| authorships[6].author.display_name | Mark Dolev |
| authorships[6].countries | IL |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I16391192, https://openalex.org/I2799810450 |
| authorships[6].affiliations[0].raw_affiliation_string | Neuroimmunology Laboratory at the Multiple Sclerosis Center, Sheba Medical Center, Laura Schwarz-Kipp Research of Autoimmune Diseases, Sackler School of Medicine Tel-Aviv University, Ramat-Gann, Israel |
| authorships[6].institutions[0].id | https://openalex.org/I2799810450 |
| authorships[6].institutions[0].ror | https://ror.org/020rzx487 |
| authorships[6].institutions[0].type | healthcare |
| authorships[6].institutions[0].lineage | https://openalex.org/I2799810450 |
| authorships[6].institutions[0].country_code | IL |
| authorships[6].institutions[0].display_name | Sheba Medical Center |
| authorships[6].institutions[1].id | https://openalex.org/I16391192 |
| authorships[6].institutions[1].ror | https://ror.org/04mhzgx49 |
| authorships[6].institutions[1].type | education |
| authorships[6].institutions[1].lineage | https://openalex.org/I16391192 |
| authorships[6].institutions[1].country_code | IL |
| authorships[6].institutions[1].display_name | Tel Aviv University |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Mark Dolev |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | Neuroimmunology Laboratory at the Multiple Sclerosis Center, Sheba Medical Center, Laura Schwarz-Kipp Research of Autoimmune Diseases, Sackler School of Medicine Tel-Aviv University, Ramat-Gann, Israel |
| authorships[7].author.id | https://openalex.org/A5036220371 |
| authorships[7].author.orcid | https://orcid.org/0000-0001-9109-6818 |
| authorships[7].author.display_name | Shay Menascu |
| authorships[7].countries | IL |
| authorships[7].affiliations[0].institution_ids | https://openalex.org/I16391192, https://openalex.org/I2799810450 |
| authorships[7].affiliations[0].raw_affiliation_string | Neuroimmunology Laboratory at the Multiple Sclerosis Center, Sheba Medical Center, Laura Schwarz-Kipp Research of Autoimmune Diseases, Sackler School of Medicine Tel-Aviv University, Ramat-Gann, Israel |
| authorships[7].institutions[0].id | https://openalex.org/I2799810450 |
| authorships[7].institutions[0].ror | https://ror.org/020rzx487 |
| authorships[7].institutions[0].type | healthcare |
| authorships[7].institutions[0].lineage | https://openalex.org/I2799810450 |
| authorships[7].institutions[0].country_code | IL |
| authorships[7].institutions[0].display_name | Sheba Medical Center |
| authorships[7].institutions[1].id | https://openalex.org/I16391192 |
| authorships[7].institutions[1].ror | https://ror.org/04mhzgx49 |
| authorships[7].institutions[1].type | education |
| authorships[7].institutions[1].lineage | https://openalex.org/I16391192 |
| authorships[7].institutions[1].country_code | IL |
| authorships[7].institutions[1].display_name | Tel Aviv University |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Shay Menascu |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | Neuroimmunology Laboratory at the Multiple Sclerosis Center, Sheba Medical Center, Laura Schwarz-Kipp Research of Autoimmune Diseases, Sackler School of Medicine Tel-Aviv University, Ramat-Gann, Israel |
| authorships[8].author.id | https://openalex.org/A5012352347 |
| authorships[8].author.orcid | https://orcid.org/0000-0002-4439-3219 |
| authorships[8].author.display_name | Gil Harari |
| authorships[8].countries | IL |
| authorships[8].affiliations[0].institution_ids | https://openalex.org/I16391192, https://openalex.org/I2799810450 |
| authorships[8].affiliations[0].raw_affiliation_string | Neuroimmunology Laboratory at the Multiple Sclerosis Center, Sheba Medical Center, Laura Schwarz-Kipp Research of Autoimmune Diseases, Sackler School of Medicine Tel-Aviv University, Ramat-Gann, Israel |
| authorships[8].institutions[0].id | https://openalex.org/I2799810450 |
| authorships[8].institutions[0].ror | https://ror.org/020rzx487 |
| authorships[8].institutions[0].type | healthcare |
| authorships[8].institutions[0].lineage | https://openalex.org/I2799810450 |
| authorships[8].institutions[0].country_code | IL |
| authorships[8].institutions[0].display_name | Sheba Medical Center |
| authorships[8].institutions[1].id | https://openalex.org/I16391192 |
| authorships[8].institutions[1].ror | https://ror.org/04mhzgx49 |
| authorships[8].institutions[1].type | education |
| authorships[8].institutions[1].lineage | https://openalex.org/I16391192 |
| authorships[8].institutions[1].country_code | IL |
| authorships[8].institutions[1].display_name | Tel Aviv University |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Gil Harari |
| authorships[8].is_corresponding | False |
| authorships[8].raw_affiliation_strings | Neuroimmunology Laboratory at the Multiple Sclerosis Center, Sheba Medical Center, Laura Schwarz-Kipp Research of Autoimmune Diseases, Sackler School of Medicine Tel-Aviv University, Ramat-Gann, Israel |
| authorships[9].author.id | https://openalex.org/A5049197840 |
| authorships[9].author.orcid | |
| authorships[9].author.display_name | Shlomo Flechter |
| authorships[9].countries | IL |
| authorships[9].affiliations[0].institution_ids | https://openalex.org/I16391192, https://openalex.org/I2799810450 |
| authorships[9].affiliations[0].raw_affiliation_string | Neuroimmunology Laboratory at the Multiple Sclerosis Center, Sheba Medical Center, Laura Schwarz-Kipp Research of Autoimmune Diseases, Sackler School of Medicine Tel-Aviv University, Ramat-Gann, Israel |
| authorships[9].institutions[0].id | https://openalex.org/I2799810450 |
| authorships[9].institutions[0].ror | https://ror.org/020rzx487 |
| authorships[9].institutions[0].type | healthcare |
| authorships[9].institutions[0].lineage | https://openalex.org/I2799810450 |
| authorships[9].institutions[0].country_code | IL |
| authorships[9].institutions[0].display_name | Sheba Medical Center |
| authorships[9].institutions[1].id | https://openalex.org/I16391192 |
| authorships[9].institutions[1].ror | https://ror.org/04mhzgx49 |
| authorships[9].institutions[1].type | education |
| authorships[9].institutions[1].lineage | https://openalex.org/I16391192 |
| authorships[9].institutions[1].country_code | IL |
| authorships[9].institutions[1].display_name | Tel Aviv University |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Shlomo Flechter |
| authorships[9].is_corresponding | False |
| authorships[9].raw_affiliation_strings | Neuroimmunology Laboratory at the Multiple Sclerosis Center, Sheba Medical Center, Laura Schwarz-Kipp Research of Autoimmune Diseases, Sackler School of Medicine Tel-Aviv University, Ramat-Gann, Israel |
| authorships[10].author.id | https://openalex.org/A5077627471 |
| authorships[10].author.orcid | |
| authorships[10].author.display_name | Rina Falb |
| authorships[10].countries | IL |
| authorships[10].affiliations[0].institution_ids | https://openalex.org/I16391192, https://openalex.org/I2799810450 |
| authorships[10].affiliations[0].raw_affiliation_string | Neuroimmunology Laboratory at the Multiple Sclerosis Center, Sheba Medical Center, Laura Schwarz-Kipp Research of Autoimmune Diseases, Sackler School of Medicine Tel-Aviv University, Ramat-Gann, Israel |
| authorships[10].institutions[0].id | https://openalex.org/I2799810450 |
| authorships[10].institutions[0].ror | https://ror.org/020rzx487 |
| authorships[10].institutions[0].type | healthcare |
| authorships[10].institutions[0].lineage | https://openalex.org/I2799810450 |
| authorships[10].institutions[0].country_code | IL |
| authorships[10].institutions[0].display_name | Sheba Medical Center |
| authorships[10].institutions[1].id | https://openalex.org/I16391192 |
| authorships[10].institutions[1].ror | https://ror.org/04mhzgx49 |
| authorships[10].institutions[1].type | education |
| authorships[10].institutions[1].lineage | https://openalex.org/I16391192 |
| authorships[10].institutions[1].country_code | IL |
| authorships[10].institutions[1].display_name | Tel Aviv University |
| authorships[10].author_position | last |
| authorships[10].raw_author_name | Rina Falb |
| authorships[10].is_corresponding | False |
| authorships[10].raw_affiliation_strings | Neuroimmunology Laboratory at the Multiple Sclerosis Center, Sheba Medical Center, Laura Schwarz-Kipp Research of Autoimmune Diseases, Sackler School of Medicine Tel-Aviv University, Ramat-Gann, Israel |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://link.springer.com/content/pdf/10.1007/s00415-022-11030-0.pdf |
| open_access.oa_status | bronze |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Immune response to the third COVID-19 vaccine dose is related to lymphocyte count in multiple sclerosis patients treated with fingolimod |
| has_fulltext | True |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10137 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9998999834060669 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2734 |
| primary_topic.subfield.display_name | Pathology and Forensic Medicine |
| primary_topic.display_name | Multiple Sclerosis Research Studies |
| related_works | https://openalex.org/W2338099154, https://openalex.org/W3183961786, https://openalex.org/W1994801541, https://openalex.org/W4380150456, https://openalex.org/W2136622145, https://openalex.org/W2343984847, https://openalex.org/W2808580533, https://openalex.org/W2053484098, https://openalex.org/W4389460947, https://openalex.org/W2169569625 |
| cited_by_count | 44 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 5 |
| counts_by_year[1].year | 2024 |
| counts_by_year[1].cited_by_count | 5 |
| counts_by_year[2].year | 2023 |
| counts_by_year[2].cited_by_count | 17 |
| counts_by_year[3].year | 2022 |
| counts_by_year[3].cited_by_count | 17 |
| locations_count | 3 |
| best_oa_location.id | doi:10.1007/s00415-022-11030-0 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S175814247 |
| best_oa_location.source.issn | 0340-5354, 1432-1459 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | 0340-5354 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | Journal of Neurology |
| best_oa_location.source.host_organization | https://openalex.org/P4310319900 |
| best_oa_location.source.host_organization_name | Springer Science+Business Media |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310319900, https://openalex.org/P4310319965 |
| best_oa_location.source.host_organization_lineage_names | Springer Science+Business Media, Springer Nature |
| best_oa_location.license | |
| best_oa_location.pdf_url | https://link.springer.com/content/pdf/10.1007/s00415-022-11030-0.pdf |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Journal of Neurology |
| best_oa_location.landing_page_url | https://doi.org/10.1007/s00415-022-11030-0 |
| primary_location.id | doi:10.1007/s00415-022-11030-0 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S175814247 |
| primary_location.source.issn | 0340-5354, 1432-1459 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | False |
| primary_location.source.issn_l | 0340-5354 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | Journal of Neurology |
| primary_location.source.host_organization | https://openalex.org/P4310319900 |
| primary_location.source.host_organization_name | Springer Science+Business Media |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310319900, https://openalex.org/P4310319965 |
| primary_location.source.host_organization_lineage_names | Springer Science+Business Media, Springer Nature |
| primary_location.license | |
| primary_location.pdf_url | https://link.springer.com/content/pdf/10.1007/s00415-022-11030-0.pdf |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Journal of Neurology |
| primary_location.landing_page_url | https://doi.org/10.1007/s00415-022-11030-0 |
| publication_date | 2022-03-02 |
| publication_year | 2022 |
| referenced_works | https://openalex.org/W2204428630, https://openalex.org/W3004673556, https://openalex.org/W2049063251, https://openalex.org/W3004830622, https://openalex.org/W3158831599, https://openalex.org/W3184783758, https://openalex.org/W3174125083, https://openalex.org/W3206879504, https://openalex.org/W3199233027, https://openalex.org/W3185684363, https://openalex.org/W3154230361, https://openalex.org/W2122545833, https://openalex.org/W3007886991, https://openalex.org/W3108018139, https://openalex.org/W2163556518, https://openalex.org/W1984156843, https://openalex.org/W3168259929, https://openalex.org/W3165367963, https://openalex.org/W3190606158, https://openalex.org/W3049077722, https://openalex.org/W2095210906, https://openalex.org/W2142577589 |
| referenced_works_count | 22 |
| abstract_inverted_index | |
| cited_by_percentile_year.max | 100 |
| cited_by_percentile_year.min | 98 |
| corresponding_author_ids | https://openalex.org/A5075594305 |
| countries_distinct_count | 1 |
| institutions_distinct_count | 11 |
| corresponding_institution_ids | https://openalex.org/I16391192, https://openalex.org/I2799810450 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.8100000023841858 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.97822749 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | True |